Pharma | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Sunday
May 11, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
SUNDAY, MAY 11, 2025

dropped | Startups | Cement | Consumers | Foreign Aid | Pharma | Real Estate | Steel | Tech/IT | Telecom

A view inside of Sai Life Sciences' manufacturing facility in Bindar, Karnataka, India September 2023. Sai Life Sciences Limited/via REUTERS/File Photo
World+Biz

Indian drug manufacturers benefit from Big Pharma interest beyond China

China has for nearly 20 years been the preferred location for a range of pharmaceutical research and manufacturing services due to the low cost and speed offered by contract drugmakers there.

Photo: Courtesy
Pharma

Four directors to buy 9 lakh Square Pharma shares

Sanofi Bangladesh renamed Synovia Pharma
Pharma

Sanofi Bangladesh renamed Synovia Pharma

Pharma on a Tk1 trillion journey
Economy

Pharma on a Tk1 trillion journey

Beximco Pharmaceuticals Acquires Sanofi Bangladesh
Pharma

Beximco Pharma inks Sanofi acquisition deal

TBS Today: Pharmaceutical industry eyes on localisation of raw materials
Videos

TBS Today: Pharmaceutical industry eyes on localisation of raw materials

Two Covid-19 drugs boost Beacon Pharma’s turnover, profits
Pharma

Two Covid-19 drugs boost Beacon Pharma’s turnover, profits

Square Pharma business growth in pandemic
Pharma

Square Pharma continues business growth in pandemic

Square to start drug production in Kenya by August
Pharma

Square to start drug production in Kenya by August

Production boom for local drugmakers
Pharma

Production boom for local drugmakers

Ban lifted on production, sale of Indo-Bangla drugs
Pharma

Ban lifted on production, sale of Indo-Bangla drugs

Beacon Pharma may export drugs to Syria
Pharma

Beacon Pharma may export drugs to Syria

Indo-Bangla Pharmaceuticals’ production, marketing banned
Pharma

Indo-Bangla Pharmaceuticals’ production, marketing banned

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net